Cooperative Research Partnerships for Biodefense (U01)
The summary for the Cooperative Research Partnerships for Biodefense (U01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Cooperative Research Partnerships for Biodefense (U01): -Purpose. To support discovery/design and development of vaccines, therapeutics, immunotherapeutics, adjuvants and medical diagnostics for NIAID Category A, B, and C priority pathogens and toxins (http://www2.niaid.nih.gov/Biodefense/bandc_priority.htm). -Mechanism of Support. This RFA will utilize the U01 cooperative agreement grant mechanism. -Funds Available and Anticipated Number of Awards. $25 million available to support 15-20 awards. Awards issued under this RFA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary.
Federal Grant Title: | Cooperative Research Partnerships for Biodefense (U01) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-AI-07-003 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.856 |
CFDA Descriptions: | Microbiology and Infectious Diseases Research |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Jun 19, 2007 |
Posted Date: | Nov 29, 2006 |
Creation Date: | Nov 29, 2006 |
Archive Date: | Jul 19, 2007 |
Total Program Funding: | $25,000,000 |
Maximum Federal Grant Award: | $300,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification) Private institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public and State controlled institutions of higher education Small businesses Special district governments Independent school districts
- Additional Information on Eligibility
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Biomedical Prevention of HIV Research Education (R25)
- • Partnerships for Next Generation Biodefense Diagnostics (R01)
- • National Biocontainment Laboratories (NBLs) Operations Support Limited Competition (UC7)
- • Partnerships for Development of New Therapeutic Classes for Select Viral and Bacterial Pat...
- • Non-Antibiotic Selectable Markers for Biodefense (R21)
- • Partnerships to Improve Diagnosis and Treatment of Selected Drug-Resistant Healthcare-Asso...
- • Pharmacological Approaches to Combating Antimicrobial Resistance (R01)
- More Grants from the National Institutes of Health
- • Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development f...
- • Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development f...
- • Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/...
- • Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
- • Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the ...